Prognostic significance of early tumor shrinkage under second-line targeted therapy for metastatic renal cell carcinoma: a retrospective multiinstitutional study in Japan

Annals of Oncology ◽

10.1093/annonc/mdw373.39 ◽

2016 ◽

Vol 27 ◽

pp. vi283

Author(s):

H. Miyake ◽

S. Ozono ◽

M. Fujisawa

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Prognostic Significance ◽

Tumor Shrinkage ◽

Second Line ◽

Early Tumor Shrinkage ◽

Download Full-text

Prognostic Significance of Early Tumor Shrinkage Under Second-Line Targeted Therapy for Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Study in Japan

Molecular Diagnosis & Therapy ◽

10.1007/s40291-016-0206-3 ◽

2016 ◽

Vol 20 (4) ◽

pp. 385-392 ◽

Author(s):

Hideaki Miyake ◽

Ken-ichi Harada ◽

Seiichiro Ozono ◽

Masato Fujisawa

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Prognostic Significance ◽

Tumor Shrinkage ◽

Second Line ◽

Early Tumor Shrinkage ◽

Download Full-text

MP16-05 EARLY TUMOR SHRINKAGE UNDER SECOND-LINE TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA AS A PREDICTOR OF OVERALL SURVIVAL: A RETROSPECTIVE MULTIINSTITUTIONAL STUDY IN JAPAN

The Journal of Urology ◽

10.1016/j.juro.2017.02.511 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Keita Tamura ◽

Hideaki Miyake ◽

Seiichiro Ozono

Keyword(s):

Renal Cell Carcinoma ◽

Overall Survival ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Tumor Shrinkage ◽

Second Line ◽

Early Tumor Shrinkage ◽

Download Full-text

Early tumor shrinkage as a predictive factor of metastatic renal cell carcinoma in molecular targeted therapy: A single institutional study

Molecular and Clinical Oncology ◽

10.3892/mco.2018.1762 ◽

2018 ◽

Author(s):

Suguru Shirotake ◽

Hideyuki Kondo ◽

Takashi Okabe ◽

Soichi Makino ◽

Ryuichiro Araki ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Predictive Factor ◽

Molecular Targeted Therapy ◽

Tumor Shrinkage ◽

Early Tumor Shrinkage ◽

Download Full-text

Early tumor shrinkage is independently associated with improved overall survival among patients with metastatic renal cell carcinoma: a validation study using the COMPARZ cohort

World Journal of Urology ◽

10.1007/s00345-018-2297-4 ◽

2018 ◽

Vol 36 (9) ◽

pp. 1423-1429 ◽

Author(s):

Viktor Grünwald ◽

Marion Dietrich ◽

Gregory R. Pond

Keyword(s):

Renal Cell Carcinoma ◽

Overall Survival ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Validation Study ◽

Tumor Shrinkage ◽

Early Tumor Shrinkage ◽

Download Full-text

The magnitude of best tumor shrinkage during second-line targeted therapy affects progression-free survival but not overall survival in patients with metastatic renal cell carcinoma

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyw024 ◽

2016 ◽

Vol 46 (6) ◽

pp. 568-574 ◽

Author(s):

Hiroki Ishihara ◽

Tsunenori Kondo ◽

Kenji Omae ◽

Toshio Takagi ◽

Jumpei Izuka ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Overall Survival ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Progression Free Survival ◽

Tumor Shrinkage ◽

Second Line ◽

Download Full-text

2598 Early tumor shrinkage (eTS) - a novel endpoint for clinical studies in metastatic renal cell carcinoma (mRCC)

European Journal of Cancer ◽

10.1016/s0959-8049(16)31416-2 ◽

2015 ◽

Vol 51 ◽

pp. S510-S511 ◽

Author(s):

V. Grünwald ◽

X. Lin ◽

D. Kalanovic ◽

R. Simantov

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Clinical Studies ◽

Tumor Shrinkage ◽

Early Tumor Shrinkage ◽

Download Full-text

Prognostic ability of early tumor shrinkage on overall survival (OS) in metastatic renal cell carcinoma (mRCC) – a validation study

Annals of Oncology ◽

10.1093/annonc/mdw373.38 ◽

2016 ◽

Vol 27 ◽

pp. vi283

Author(s):

G.R. Pond ◽

M. Dietrich ◽

V. Grünwald

Keyword(s):

Renal Cell Carcinoma ◽

Overall Survival ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Validation Study ◽

Tumor Shrinkage ◽

Early Tumor Shrinkage ◽

Download Full-text

Early tumor shrinkage (eTS) as a predictive and prognostic factor in metastatic renal cell carcinoma (mRCC).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.4551 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 4551-4551 ◽

Author(s):

Viktor Gruenwald ◽

Xun Lin ◽

Daniel Kalanovic ◽

Ronit Simantov

Keyword(s):

Renal Cell Carcinoma ◽

Prognostic Factor ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Tumor Shrinkage ◽

Early Tumor Shrinkage ◽

Download Full-text

2605 Early tumor shrinkage under treatment with first-line tyrosine kinase inhibitors as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma

European Journal of Cancer ◽

10.1016/s0959-8049(16)31423-x ◽

2015 ◽

Vol 51 ◽

pp. S513

Author(s):

H. Miyake ◽

H. Momozono ◽

M. Fujisawa

Keyword(s):

Renal Cell Carcinoma ◽

Overall Survival ◽

Cell Carcinoma ◽

Kinase Inhibitors ◽

Surrogate Endpoint ◽

Tumor Shrinkage ◽

Early Tumor Shrinkage ◽

Download Full-text

Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settings

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2016.02.023 ◽

2016 ◽

Vol 34 (7) ◽

pp. 293.e17-293.e25 ◽

Author(s):

Nobuyuki Tanaka ◽

Ryuichi Mizuno ◽

Suguru Shirotake ◽

Keiichi Ito ◽

Yota Yasumizu ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Targeted Therapy ◽

Cell Carcinoma ◽

Metastatic Renal Cell Carcinoma ◽

Second Line ◽

Download Full-text